Online
|
|
Zenotech Laboratories open offer at Rs.160 will be decided on Dec 2 2009....recommend a strong buy at CMP of Rs.116 -120 .....Buy Buy Buy
Posted by :
world investor
Just hold and don`t even think of selling Zentech Labs...
Daichi Sanko needs this company badly...
Ranbaxy has 47% stake in Zenotech..
Ranbaxy has been taken over by Daichi...
Daichi will finally agree to the open offer on Dec 2nd 2009...
So I would advise investors to hold and even buy at CMP...... ...
Zenotech Laboratories open offer at Rs.160 will be decided on Dec 2 2009....recommend a strong buy at CMP of Rs.116 -120 .....Buy Buy Buy
Posted by :
psmini
will the offer remain same with such news from BS
Zenotech Labs June qtr net loss widens to Rs 3.41 cr
Press Trust of India / Mumbai November 16, 2009, 16:04 IST
Drug maker Zenotech Laboratories today said reported Rs 3.41 crore loss for the quarter ended June 30, against a net loss of Rs 2.66 crore in the same period previous fiscal.
The board today approved the results for the financial year ended March 31, and first quarter ended June 30, 2009, Zenotech Laboratories said in a filing to the Bombay Stock Exchange (BSE).
The board meeting was scheduled to be held on October 9, 2009, was postponed to November 16, 2009, the filing added.
Total income declined to Rs 1.07 crore in the latest quarter ended June 30, against Rs 2.77 crore in the same period corresponding year, it said.
The company also reported net loss of Rs 10.79 crore for the quarter ended March 31, against Rs 6.65 crore in the same period previous year.
For the year ended March 31, the company reported a net loss of Rs 21.67 crore, against a net loss of Rs 14.70 crore in the same period previous fiscal.
Shares of Zenotech Laboratories today closed at Rs 115.25 on the BSE, down 0.73 per cent from its previous close.
...
BSE Announcements on Zenotech Labs
Posted by : MMB Messenger
Zenotech Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 16, 2009, inter alia, has approved the following:
1. Notice for the Annual General Meeting is yet to be approved due to the nominations notices received by the Company in respect of appointment of two Directors. In view of this the notice of 19th Annual General Meeting and the date would be finalized later with the leave of Honble Company Law Board.
2. The Company allotted 4250 shares under Zenotech Employee Stock Option Scheme, 2005 but this resolution will be implemented only with the leave of Honble Company Law Board, in view of orders passed by Honble Company Law Board in CA 116 of 2009, in CP 51 of 2009 Dt. November 13, 2009....
Zenotech Laboratories open offer at Rs.160 will be decided on Dec 2 2009....recommend a strong buy at CMP of Rs.116 -120 .....Buy Buy Buy
Posted by : world investor
Just hold and don`t even think of selling Zentech Labs...
Daichi Sanko needs this company badly...
Ranbaxy has 47% stake in Zenotech..
Ranbaxy has been taken over by Daichi...
Daichi will finally agree to the open offer on Dec 2nd 2009...
So I would advise investors to hold and even buy at CMP......
Zenotech Laboratories open offer at Rs.160 will be decided on Dec 2 2009....recommend a strong buy at CMP of Rs.116 -120 .....Buy Buy Buy
Posted by : ashwanikr07@yah
i m holding 1000 shares of zenotech lab .what should i do....................
should i hold or quit...
Zenotech Laboratories open offer at Rs.160 will be decided on Dec 2 2009....recommend a strong buy at CMP of Rs.116 -120 .....Buy Buy Buy
Posted by : world investor
Also the Supreme Court may direct Daichi to pay interest at the rate of 8% - 14% on the open price of Rs.160 tpo the shareholders for the delay in the open offer...
I recommend investors to buy at CMP of Rs.115 - 117 for reaping the harvests on 2nd dec 2009.......
Zenotech Laboratories open offer at Rs.160 will be decided on Dec 2 2009....recommend a strong buy at CMP of Rs.116 -120 .....Buy Buy Buy
Posted by : world investor
The final date of hearing of the open offer decision has been fixed for December 02, 2009.
This is a great oppurtunity to make money by buying Zenotech Laboratories as the decision by the Supreme Court will be in favour of the shareholders of the open offer at Rs.160...
I recommend a strong buy at current levels of Rs.116 - 125 for a 25% - 30 % returns .......
BSE Announcements on Zenotech Labs
Posted by : MMB Messenger
ICICI Securities Ltd ("Manager to the Offer") for and on behalf of Daiichi Sankyo Company Ltd ("Acquirer") has issued this Corrigendum to the Public Announcement to the Equity Shareholders of Zenotech Laboratories Ltd ("Target Company"), which is in continuation of and should be read in conjunction with the Public Announcement ("PA") published on January 19, 2009, the corrigendum published on March 02, 2009 ("First Corrigendum"), the corrigendum published on July 10, 2009 ("Second Corrigendum"), the Letter of Offer ("LOF") and the announcement dated July 14, 2009 ("Announcement"), the corrigendum published on August 05, 2009 ("Third Corrigendum") & the corrigendum published on August 08, 2009 ("Fourth Corrigendum"), Pursuant to Regulations 10 and 12 of and as required by under the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 as amended ("Regulations") in connection with the Open Offer made by the Acquirer to the equity shareholders (other than the parties to the Share Purchase and Share Subscription Agreement dated June 11, 2008) of Target Company, to acquire 68,86,000 fully paid-up equity shares of face value of Rs 10/- each representing 20% of the Emerging Voting Capital of Target Company ("Offer").
The shareholders of the Target Company are requested to note the following:
1. Appeal before the Securities Appellate Tribunal and consequent appeal to Supreme Court:
As disclosed in the Third Corrigendum and the Fourth Corrigendum, Dr Jayaram Chigurupati and Mr. Narayanan, both of whom are shareholders in Target Company had, against certain orders passed by the Securities and Exchange Board of India in connection with the Offer, filed appeals before the Securities Appellate Tribunal ("SAT). SAT, by its orders dated October 07, 2009 ("SAT Orders") had allowed the appeals filed by Dr. Jayaram Chigurupati and Mr. Narayanan and directed the Acquirer to offer Rs. 160 to the shareholders of Target Company.
The Acquirer has since filed appeals against the SAT Orders before the Honble Supreme Court of India ("Supreme Court"). On October 28, 2009, the Supreme Court passed an order admitting the appeal filed against the SAT Order in the matter of Dr. Jayaram Chigurupati Vs SEBI and Others and directed that status quo be maintained with respect to the Offer. The final date of hearing has been fixed for December 02, 2009.
On November 05, 2009, the Supreme Court passed a similar order admitting the appeal filed against the SAT order in the matter of Mr. Narayanan Vs SEBI and directed that status quo be maintained with respect to the Offer. The final date of hearing has been fixed for December 02, 2009.
Meanwhile, in light of the Supreme Court order dated November 05, 2009, SAT, by its order dated November 06, 2009 has dismissed the miscellaneous application previously filed by Mr. Narayanan requesting certain clarification in connection with his Appeal before SAT and which was scheduled to come up for hearing before SAT on November 06, 2009.
2. Petitions before the Company Law Board, Chennai ("CLB")
In addition, and as disclosed in the LOF, a petition had been filed before the CLB by Dr. Jayaram Chigurupati and others ("Petitioners") under Sections 397 and 398 read with Sections 402 and 403 of the Companies Act, 1956, as amended ("Act"). Following the Fourth Corrigendum, the Petitioners had filed an application to the CLB to appoint certain persons as independent directors to the Board of Directors of the Target Company. While the application was pending, on October 01, 2009, a meeting of the Board was convened and at such meeting, the resignations of certain directors were accepted and Mr. M.R. Vikram along with Dr. K. Uma Devi were appointed as directors to the Board. Subsequently, the Petitioners withdraw their application and Ranbaxy Laboratories Ltd ("RLL") filed an application to the CLB to declare the appointment of Mr. M.R. Vikram and Dr. K. Uma Devi as invalid. By its order dated October 21, 2009, the CLB held that the appointment of Mr. M.R. Vikram and Dr. K. Uma Devi is valid. The matter is scheduled to come up for hearing on November 13, 2009.
Apart from the above, and following the Fourth Corrigendum, RLL has filed a petition before the CLB under Sections 397 and 398 read with Sections 402 and 403 of the Act. Dr. Jayaram Chigurupati, Zenotech LLC, Target Company, and Mrs. Chigurupati have been named as the respondents ("Respondents"). The Acquirer has also been made a party to this petition. The petition is in connection with the alleged mismanagement and oppression by Dr. Jayaram Chigurupati and certain other persons named in the petition. The matter is scheduled to come up for hearing on November 13, 2009.
All other terms and conditions of the Offer remain unchanged. The terms used but not defined in this Corrigendum shall have the same meaning as assigned in the PA, the First Corrigendum, the Second Corrigendum, the LOF, the Announcement, the Third Corrigendum and/ or the Fourth Corrigendum. ...
Hey,
Torrant Pharma is really doing good.it reached to 400 and today @372.What is the future target?At what price can we enter this stock again ?
Thanks...
BSE Announcements on Zenotech Labs
Posted by : MMB Messenger
Zenotech Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 16, 2009, inter alia, to consider the following:
1. Financial results for the year ended March 31, 2009.
2. Un-audited financial results for the Quarter ended June 30, 2009.
3. To consider the matters relating to conduct the 19th Annual General Meeting for the year ended March 31, 2008 and for this purpose to approve the Notice calling 19th Annual General Meeting, Directors Report includes Report on Management Discussion and Analysis forming part of Directors report and Corporate Governance Report.
4. To allot the shares against the exercise of stock options granted under Zenotech Employees Stock Option Scheme, 2005....
CAN I ENTER IN THIS SCRIPT NOW.....
Last hearing in SC scheduled on 2nd December.Daiichi have said they would up the offer price to 160 if decision goes against them...
BSE Announcements on Zenotech Labs
Posted by : MMB MessengerZenotech Laboratories Ltd has informed BSE that the appointment of two directors on October 01, 2009 was challenged by Ranbaxy Laboratories Ltd. and the Honble Company Law Board vide its order dated October 21, 2009 has upheld the appointment of the said directors....
Hi.
I have arnd 25-30k running on this stock @ 128.Please suggest on its future prospect.
Thanks in advance...
should we buy/sell this stock?...
